Neurogene Inc. Net Cash Provided by (Used in) Financing Activities in USD from 2016 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Neurogene Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2016 to Q1 2025.
  • Neurogene Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2025 was $4K.
  • Neurogene Inc. annual Net Cash Provided by (Used in) Financing Activities for 2024 was $184M, a 99% increase from 2023.
  • Neurogene Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $92.5M, a 39% increase from 2022.
  • Neurogene Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $66.5M, a 8989% increase from 2021.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)

Neurogene Inc. Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2025 $4K +$6.53M Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-09
Q1 2024 -$6.52M -$6.63M -6197% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-09
Q1 2023 $107K -$26K -19.5% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-10
Q1 2022 $133K -$149K -52.8% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-08
Q1 2021 $282K -$3.11M -91.7% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q1 2020 $3.39M +$3.39M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-12
Q1 2019 -$2K -$201K -101% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-06
Q1 2018 $199K +$203K Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-07
Q1 2017 -$4K Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-08

Neurogene Inc. Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $184M +$91.6M +99% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-24
2023 $92.5M +$26M +39% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-24
2022 $66.5M +$65.8M +8989% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-18
2021 $732K -$76.4M -99.1% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-20
2020 $77.1M -$5.1M -6.2% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-01
2019 $82.2M +$81.7M +14328% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-25
2018 $570K +$147K +34.8% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-12
2017 $423K -$70.7M -99.4% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-12
2016 $71.1M Jan 1, 2016 Dec 31, 2016 10-K 2019-03-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.